Market Overview

The Promise of Telepsychiatry: Implications for Clinical Research in a Post-COVID Era, Upcoming Webinar Hosted by Xtalks

Share:

In this free webinar, the featured speakers will discuss the considerations and challenges of developing a decentralized clinical trial (DCT) from a sponsor perspective and considerations for investigators. Attendees will learn how to operationalize a DCT trial, how real-time patient dosing is monitored and how digital biomarkers are measured.

TORONTO (PRWEB) October 13, 2020

Telepsychiatry has always offered a tantalizing solution to the significant undertreatment of mental illness. With COVID-19, widespread stay-at-home measures and reduced offerings for face-to-face mental health services has skyrocketed the demand for in-home care and accelerated the promise of telepsychiatry.

Innovative decentralized or virtual trials are taking telepsychiatry in mental health research to the next level—that is, bringing it to the patient's home.

During this interactive discussion, panelists will highlight the patient journey for a fully decentralized major depressive disorder (MDD) trial, including methodology for centralized raters, real-time patient dosage monitoring, and patient behavior insights from measured digital biomarkers to evaluate depression. We will also share insights for effective recruitment of a diverse patient population using a digital approach to attract and then engage participants.

The decentralized or virtual research model has become the standard in the current climate and this shift is helping to unlock the promise of telepsychiatry.

Join Thuy Le Nguyen, MPH, Senior Associate Director, Boehringer Ingeheim, Christopher Reist, MD, MBA, Medical Director, Psychiatry and Behavioral Science, Science 37, Isaac Galatzer-Levy, PhD, Chief Scientific Officer, AiCure and Gary Sachs, MD, Clinical Vice President, Signant Health in a live webinar on Friday, October 23, 2020 at 9am EDT (1pm BST/UK).

For more information or to register for this event, visit The Promise of Telepsychiatry: Implications for Clinical Research in a Post-COVID Era.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

For the original version on PRWeb visit: https://www.prweb.com/releases/the_promise_of_telepsychiatry_implications_for_clinical_research_in_a_post_covid_era_upcoming_webinar_hosted_by_xtalks/prweb17461952.htm

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com